Predicting the Future: The Promise of New Tests for Prostate Cancer

Speaker: Dr. John Lewis
Original Date: Tuesday, July 22, 2014
 

Join Dr. John Lewis as he presents "Predicting the Future: The Promise of New Tests for Prostate Cancer."
 
Overview:
During this webinar, Dr. John Lewis will be discussing the use of biomarkers in prostate cancer diagnosis, including:

  • How biomarkers such as PSA are used today for prostate cancer management
  • How new biomarkers will allow patients and their physicians to make better treatment decisions

Speaker – Dr. John Lewis

Dr. John Lewis holds the Frank and Carla Sojonky Chair in Prostate Cancer Research at the University of Alberta. He is an Associate Professor in the Department of Oncology, a Fellow of the National Institute of Nanotechnology, and currently serves as the chair of the Alberta Prostate Cancer Research Initiative (APCaRI).  Dr. Lewis received his B.Sc. Honours in Genetics at University of Western Ontario in the Department of Genetics and a PhD in Biochemistry at the University of Victoria in 2003. He pursued post-doctoral training in Nanotechnology and Imaging at The Scripps Research Institute in La Jolla, CA. Dr. Lewis's research group utilizes real-time intravital imaging of cancer to learn about the critical steps of disease progression. They have developed several innovative nanoparticle platforms for the early detection of cancer, drug delivery, and the study of cancer invasion and metastasis. Dr. Lewis is actively involved in advocacy and public awareness programs for prostate cancer, and enjoys surfing, snowboarding and mountain biking in his spare time. 

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More

Plaid for Dad participation skyrockets in third year

July 7, 2017 - TORONTO, ON - Launched for the first time in 2015, Prostate Cancer Canada's (PCC) Plaid for Dad campaign has further established itself as the way Canadians are choosing to give back on Father's Day weekend.
More


Click here for news archive